Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 33.40
-0.50 (-1.47%)
May 14, 2026, 4:00 PM EDT
SHA:688139 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 219.93 | 250.73 | 366.63 | 406.07 | 600.79 | 845.04 |
Depreciation & Amortization | 113.34 | 113.34 | 120.53 | 103.44 | 64.18 | 50.95 |
Other Amortization | 14.53 | 14.53 | 1.84 | 1.4 | 0.42 | 0.77 |
Loss (Gain) From Sale of Assets | -0.63 | -0.63 | -0.23 | 1.6 | 0.31 | - |
Asset Writedown & Restructuring Costs | 1.23 | 1.23 | 1.86 | 5.31 | 0.45 | 1.85 |
Loss (Gain) From Sale of Investments | -26.81 | -26.81 | -29.26 | -85.09 | -67.71 | -483.48 |
Provision & Write-off of Bad Debts | 13.39 | 13.39 | 16.03 | 5.82 | 1.12 | -3.86 |
Other Operating Activities | -7.47 | -12.72 | -0.31 | -7.05 | 54.28 | 41.39 |
Change in Accounts Receivable | -68.68 | -68.68 | -173.74 | 52.35 | -37.55 | 67.46 |
Change in Inventory | -18.65 | -18.65 | -68.72 | 38.34 | 76.78 | -99.12 |
Change in Accounts Payable | 34.07 | 34.07 | 76.51 | -252.2 | -72 | 124.42 |
Change in Other Net Operating Assets | - | - | - | - | 3.9 | 53.01 |
Operating Cash Flow | 242.35 | 267.89 | 291.67 | 249.26 | 632.43 | 591.8 |
Operating Cash Flow Growth | -3.71% | -8.15% | 17.01% | -60.59% | 6.87% | -15.05% |
Capital Expenditures | -106.73 | -119.25 | -126.7 | -177.18 | -294.24 | -204.69 |
Sale of Property, Plant & Equipment | 0.46 | 0.46 | 0.82 | 1.35 | 0.16 | 20.92 |
Cash Acquisitions | -11.65 | -56.65 | -160.41 | -214.99 | -115.35 | - |
Divestitures | - | - | - | - | - | 459.68 |
Investment in Securities | 278.56 | 170.12 | -521.03 | 573.19 | 66.02 | -1,827 |
Other Investing Activities | 17.21 | 22.07 | 16.11 | 70.38 | 92.24 | 49.21 |
Investing Cash Flow | 177.85 | 16.75 | -791.22 | 252.76 | -251.17 | -1,501 |
Short-Term Debt Issued | - | 737.97 | 189.52 | 6 | - | - |
Total Debt Issued | 727.97 | 737.97 | 189.52 | 6 | - | - |
Short-Term Debt Repaid | - | -730.01 | -198.59 | -22.5 | -5 | -25 |
Long-Term Debt Repaid | - | -6.71 | -4.36 | -5.87 | -1.87 | -1.71 |
Total Debt Repaid | -736.73 | -736.72 | -202.95 | -28.37 | -6.87 | -26.71 |
Net Debt Issued (Repaid) | -8.77 | 1.24 | -13.43 | -22.37 | -6.87 | -26.71 |
Issuance of Common Stock | - | - | - | - | 36.89 | - |
Repurchase of Common Stock | -108.48 | -108.48 | -40.46 | -1.67 | -98.07 | - |
Common Dividends Paid | -147.37 | -147.36 | -163.09 | -142.8 | -162.46 | -120.83 |
Other Financing Activities | 12.43 | -14.14 | -9.86 | -1.46 | 24.27 | 11.52 |
Financing Cash Flow | -252.2 | -268.74 | -226.83 | -168.3 | -206.23 | -136.01 |
Foreign Exchange Rate Adjustments | -5.44 | 3.2 | 4.43 | -8.24 | 8.9 | -1.54 |
Net Cash Flow | 162.56 | 19.1 | -721.94 | 325.48 | 183.92 | -1,047 |
Free Cash Flow | 135.62 | 148.64 | 164.96 | 72.08 | 338.18 | 387.11 |
Free Cash Flow Growth | -1.35% | -9.89% | 128.85% | -78.69% | -12.64% | -36.29% |
Free Cash Flow Margin | 5.92% | 6.38% | 7.22% | 3.16% | 11.81% | 18.21% |
Free Cash Flow Per Share | 0.43 | 0.47 | 0.52 | 0.23 | 1.06 | 1.22 |
Cash Income Tax Paid | 119.93 | 99.78 | 104.17 | 103.09 | 137.86 | 120.93 |
Levered Free Cash Flow | 17.34 | -311.57 | 4.09 | -221.96 | 225.74 | 168.55 |
Unlevered Free Cash Flow | 19.78 | -309.12 | 6.22 | -219.77 | 227.41 | 170.36 |
Change in Working Capital | -85.15 | -85.15 | -185.43 | -182.24 | -21.4 | 139.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.